Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Additional filings and positive clinical results for Zadaxin

Dec. 23, 1996

Takeda claims new treatments for pancreatitis

Dec. 23, 1996

Novel 5-HT4 receptor agonist claimed by Pharmacia & Upjohn

Dec. 13, 1996

Roberts in-licenses another GI drug from Lilly

Dec. 10, 1996

Successful phase III results reported for British Biotech PAF antagonist

Dec. 9, 1996

Cytel to implement new development strategy for HBV vaccine

Dec. 6, 1996

Phase IIa trial on Isis antiinflammatory antisense compound completed

Dec. 5, 1996

Axcan-Schwarz joint venture to market URSO

Dec. 2, 1996

Chugai discloses erythromycins for gastrointestinal disorders

Nov. 27, 1996

OraVax and Pasteur-Merieux Connaught license H. pylori genome sequence

Nov. 26, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for June 3, 2025.
Regeneron boosts obesity pipeline with Hansoh’s GLP-1/GIP for $2B
BioWorld
Regeneron Pharmaceuticals Inc. is adding to its obesity pipeline by in-licensing Hansoh Biomedical Co. Ltd.’s phase III dual glucagon-like peptide 1...
ASCO 2025: Verastem has positive cancer data but stock sags
BioWorld
New dose-escalation data from Verastem Oncology’s phase I/II cancer study in China prompted the company to say it was encouraged by the efficacy results. However,...
Pan-cancer proteome atlas reveals new biomarkers and targets
BioWorld Science
An international group of scientists has completed the first draft of The Pan-Cancer Proteome Atlas (TPCPA). The project is based on mass spectrometry of 22...